首页 | 本学科首页   官方微博 | 高级检索  
检索        


Clinical translation of ferumoxytol‐based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population
Authors:Jill Fredrickson  Natalie J Serkova  Shelby K Wyatt  Richard AD Carano  Andrea Pirzkall  Ina Rhee  Lee S Rosen  Alberto Bessudo  Colin Weekes  Alex de Crespigny
Institution:1. Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA;2. Oncology Clinical Development, Genentech, Inc., South San Francisco, California, USA;3. Department of Anesthesiology, University of Colorado Cancer Center, Aurora, Colorado, USA;4. Department of Biomedical Imaging, Genentech, Inc., South San Francisco, California, USA;5. Department of Medicine, Division of Hematology and Oncology, UCLA, Santa Monica, California, USA;6. San Diego Pacific Oncology Hematology Associates Inc., Encinitas, California, USA;7. Department of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA
Abstract:
Keywords:angiogenesis  tumor  vessel size  DCE‐MRI  USPIO  VSI
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号